Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting

Completed

• Conditions: Sarcoma; Melanoma

• Registration Number: NCT01034696
• Lead Sponsor: Royal Marsden NHS Foundation Trust

Brief Summary

The primary objective of this research project is to estimate the number of patients with sarcoma or melanoma attending an outpatients clinic that are in pain or have unmet pain needs.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-05
• Study First Submitted: 2009-12-16
• Study First Submitted QC: 2009-12-16
• Study First Posted: 2009-12-17
• Primary Completion: 2010-01
• Study Completion: 2010-01
• Status Verified: 2016-05
• Last Update Submitted: 2016-05-20
• Last Update Posted: 2016-05-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• Diagnosis of sarcoma or melanoma cancer
• Able to respond to an assessment in written English.
• Able to provide informed consent to participate in the study.

Exclusion Criteria

• Patients whose health would be compromised by participation in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of patients with significant pain and the proportion of patients with a negative score on the pain management index (PMI)

Secondary Outcome Measures

Name	Time	Method
Proportion of patients with neuropathic pain.
We will also seek to identify potential predictors of pain intensity in patients that do have pain. In addition to the risk factors already mentioned above, duration and cause of pain will also be tested in this case as potential pain predictors.
Potential predictors of pain. The variables tested as potential risk factors will be age, tumour type, gender and treatment type.

Trial Locations

Locations (1)

Royal Marsden Hospital; 🇬🇧 Sutton, Surrey, United Kingdom